Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/188740
Kind Code:
A1
Abstract:
The disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.

More Like This:
JP7054387Bifunctional prodrug
JP2023548045Fusions with CD8 antigen binding molecules to modulate immune cell function
JP6892826CD48 antibody and its complex
Inventors:
SONG PAUL H (CN)
QIN GANG (CN)
LIU CHONG (CN)
Application Number:
PCT/CN2022/079523
Publication Date:
September 15, 2022
Filing Date:
March 07, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN)
International Classes:
A61K47/65; A61P35/00; C07K16/28
Domestic Patent References:
WO2021136475A12021-07-08
WO2021136483A12021-07-08
WO2015165413A12015-11-05
WO2014056333A12014-04-17
WO2018170179A12018-09-20
WO2020016662A22020-01-23
WO2020200196A12020-10-08
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: METHOD, DEVICE AND PROGRAM PRODUCT FOR GLASS BENDING

Next Patent: TIME ALIGNMENT MANAGEMENT